JPRN-UMIN000002244已完成未知
A phase 3 study of gemcitabine and S-1 compared with gemcitabine monotherapy in patients with unresectable advanced pancreatic cancer. - A phase 3 study of GEM and S-1 compared with GEM for unresectable advanced pancreatic cancer.
Chiba Cancer Center0 个研究点目标入组 100 人开始时间: 2009年7月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)severe concurrent disease, (2)interstitial pneumonia, (3)massive abdominal or pleural effision (4)mental disoeder, (5)active concomitant malignancy, (6)severe diarrhea, (7)brain metastasis, (8)severe drug hypersensitibity, (9)pregnant or lactating females, (10)regular use of phenytoin, warfarin or frucitocin, (11)inappropriate for entry onto the study, as diagnosed by primary physician.
研究者
相似试验
已完成
3 期
Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer (JCOG1113, FUGA-BT)nresectable or recurrent bilary tract cancerJPRN-UMIN000010667Japan Clinical Oncology Group (JCOG)350
已完成
2 期
Phase II/III study of Gemcitabine and S-1 (GS therapy) as Neoadjuvant chemotherapy for resectable pancreatic cancer (Prep-02/JSAP-05)JPRN-UMIN000009634Study group of preoperative therapy for pancreatic cancer (PREP)/Japanese Study Group of Adjuvant Therapy for pancreatic Cancer (JSAP)364
已完成
2 期
Phase II study of gemcitabine and S-1 combination therapy in advanced pancreatic cancer with malignant ascites.pancreatic cancer with ascitesJPRN-UMIN000003269ational Cancer Center Hospital East Hepatobiliary and Pancreatic Oncology Division36
招募中
1 期
Phase I/II study of Gemcitabine and S-1 (GS therapy) as Neoadjuvant chemoradiationtherapy for borderline resectable pancreatic cancer (Prep-03/NS014-1)Borderline resectable pancreatic cancerJPRN-UMIN000014498Study group of preoperative therapy for pancreatic cancer (PREP)40
招募中
1 期
Prep-03C535836Pancreatic cancerpancreatic cancerJPRN-jRCTs021180045nno Michiaki40